WHY SUBMIT TO ISCT 2024?
A Truly Translational Focus on a Global Platform
Whether you focus on basic science and preclinical studies, clinical investigations, manufacturing, regulatory, quality, policy, ethics, or commercialization, your work is vital to advancing the field of cell and gene therapy. ISCT is the place for you to discuss your research with a global community of experts across the translation field.
Showcase Your Research - Get Feedback, Collaborate
Be considered for an oral abstract, elevator pitch presentation, or poster presentation and promote your work to global leaders in the cell and gene therapy sector. Gain exposure to key opinion leaders, potential collaborators, future employers, and expand your professional network.
Publish Your Work
Accepted abstracts will be published in a special supplement of Cytotherapy, the official journal of ISCT. With a 5-year Impact Factor of 5.0 and a global readership, Cytotherapy represents an excellent platform to highlight your work to a translational audience. Many studies first presented at ISCT Annual Meetings go on to be published as full-length articles.
Qualify for Awards
ISCT recognizes outstanding abstracts and presentations. AT ISCT 2023 Paris, 15 winners were awarded a combined total of $16,000. Submit an abstract and join ISCT to qualify!
Launch Your Career
ISCT is invested in the future of our sector and has created exclusive opportunities for Early Stage Professionals to present their work at ISCT 2024. Students, recent grads, and postdocs are encouraged to submit.